- Clearmind Medicine (NASDAQ:CMND) disclosed in an SEC filing on Monday after the bell a prospectus to offer and sell common shares, subscription rights, warrants, and units to raise $50 million.
- The prospectus is not an offer to sell the securities and is not soliciting an offer to buy the securities.
- SEC filing.
Trending
- ‘I want to die “young” as late as possible,’ says 83-year-old triathlete doctor who reinvented himself after a midlife crisis
- 10 Israeli Soldiers Hospitalized After Wasp Swarm Attack
- Construction Partners posts strong Q2 amid high demand By Investing.com
- ZIM Integrated sails to top industrial gainer of week, Builders FirstSource sees loser tag
- US Marine Says 40% of Drones the IDF Has Shot Down Were Their Own
- Amprius Technologies doubles customer base, boosts revenue By Investing.com
- My 19-year-old son wants to get married so Uncle Sam will ‘kick in more scratch’ for his girlfriend’s financial aid. Is this a terrible idea?
- Meet the Doomsayers Waiting for the Economy to Crash
Friday, March 6
Clearmind Medicine files for $50M mixed shelf (NASDAQ:CMND)
By 
